Holen Sie sich die Stockscreener-App
2.17
19.46%
0.32
Cellectis Adr Aktie (CLLS) Neueste Nachrichten
Cellectis shares surge 66% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India
European Stocks Falter On Wall Street As ADR Index Drops - Finimize
European Equities Slip While Biopharma Stocks Shine - Finimize
European Stocks Shine As ADRs Climb Higher - Finimize
European ADRs Dip With Some Stocks Rising Above The Crowd - Finimize
Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com South Africa
Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year - Investing.com
Cellectis S.A. announces board change and meeting By Investing.com - Investing.com India
Cellectis S.A. announces board change and meeting - Investing.com
European Equities See Growth In US Trade - Finimize
Cellectis earnings beat by $0.07, revenue topped estimates - Investing.com
Cellectis earnings beat by $0.06, revenue topped estimates - Investing.com India
Cellectis Charts Course For 2025 With Boost From AstraZeneca Deal - Barchart.com
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView
Cellectis stock touches 52-week low at $1.14 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView
Cellectis’s SWOT analysis: biotech firm’s stock faces CAR T challenges - Investing.com
Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% By Investing.com - Investing.com South Africa
Cellectis stock touches 52-week low at $1.2 amid market challenges - Investing.com India
Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% - Investing.com India
What Recent Market Trends Mean for Cosan S.A ADR’s (CSAN) Stock - The News Heater
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week - TradingView
Cellectis stock touches 52-week low at $1.24 amid market challenges - Investing.com India
European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView
StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS) - MarketBeat
Cellectis earnings missed by $0.20, revenue fell short of estimates - Investing.com
Cellectis stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
Cellectis stock touches 52-week low at $1.4 amid market challenges - Investing.com India
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewswire Inc.
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView
This Penny Stock Has 270% Upside Potential in 2025. Is It a Buy Now? - Barchart.com
Analysts Predict 400% Upside Potential for This Penny Stock - Yahoo Finance
Cellectis stock plunges to 52-week low at $1.52 amid market challenges - Investing.com
3.67%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):